WHO (TobReg) Technical Report and Recommendations: ‘ENDS’

Status
Not open for further replies.

Tom09

Super Member
ECF Veteran
Feb 22, 2009
504
125
Germany
The WHO tobacco Free Initiative announces the third volume of the WHO Study Group on tobacco Product Regulation (TobReg) Technical Report Series on the Scientific Basis of tobacco Product Regulation. This WHO Technical Report Series makes available the findings of an international group of experts that provide WHO with the latest scientific and technical advice in the area of product regulation.
Source: WHO (TobReg), February 2010


From the actual document WHO Technical Report Series 955:
2.1 Preface
This Scientific Recommendation addresses electronic nicotine delivery systems (ENDS) designed for nicotine delivery to the respiratory system. [...]
This recommendation is being made because ENDS pose significant public health issues and raise questions for tobacco control policy and regulation. Manufacturers have not fully disclosed the chemicals used in ENDS; there are few data on their emissions or actual human exposure; their health effects have not been studied; and their marketing and use could undermine public smoking bans, which are important tobacco control interventions. The products could also undermine smoking cessation efforts by proposing unproven devices for smoking cessation in the place of products of proven efficacy. ENDS might also undermine the prevention of tobacco use because of their appearance and marketing as safe alternatives to tobacco products for nontobacco users, including children. [...]

4.1.1 Main recommendations
ENDS designed for direct nicotine delivery to the respiratory system fall into a regulatory gap in most countries, escaping regulation as drugs and avoiding the controls on tobacco products. There is currently insufficient evidence to assess whether ENDS products could be used to aid cessation, create or sustain addiction, or deliver constituents other than nicotine to smokers. Clinical trials, behavioural and psychological studies and post-marketing studies at individual and population levels are needed to answer these questions. Claims imputing health benefits, reduced harm or use in smoking cessation should be prohibited until they are scientifically proven. ENDS products should be regulated as nicotine delivery devices; when such regulation is not possible, they should be subjected under tobacco control laws to regulation of contents and labelling, prohibitions against public use and restrictions on advertising, promotion and sponsorship. [...]
 

tarheeldan

Super Member
ECF Veteran
Feb 2, 2010
632
1
40
Dover, NH
.1 Preface - tarheeldan's version
This Scientific Recommendation addresses electronic nicotine delivery systems (ENDS) designed for nicotine delivery to the respiratory system. [...]
This recommendation is being made because ENDS pose significant public health issues far less worrisome than tobacco cigarette consumption and raise questions for tobacco taxation and price elasticity of demand given an increased degree of substitutability. Manufacturers have not fully disclosed the chemicals used in ENDS, whereas an approximation of 4,000 chemicals are well documented in cigarettes; there are few data on their emissions or actual human exposure besides 5 years of consumer experience without incidence; their health effects have not been studied in a manner which promotes the financial interests of internationally important fiscal entities i.e. pharmaceutical and tobacco interests; and their marketing and use could undermine public smoking bans (albeit ENDS do not produce products of combustion per se), which are important tobacco control interventions. The products could also undermine smoking cessation efforts by proposing unproven devices for smoking cessation in the place of products of proven efficacy in revenue stream generation. ENDS might also undermine the prevention of tobacco use because of their appearance and marketing as safe alternatives to tobacco products for nontobacco users, including children who would otherwise have opted for traditional, harmful tobacco delivery by commandeering said products from their progenitors. Budget constraints, lack of availability, and non-existence of marketing toward said groups should be assumed non-binding constraints as pertains to this issue [...]

4.1.1 Main recommendations - tarheeldan's version
ENDS designed for direct nicotine delivery to the respiratory system fall into a regulatory gap in most countries, escaping regulation and monopolistic competition as drugs and avoiding the controls and taxes on tobacco products. There is currently insufficient evidence to assess whether ENDS products could be used to aid cessation (aside from a rapidly increasing successful consumer base), create or sustain addiction, or deliver constituents other than nicotine (and known additives and suspension fluids) to smokers. Clinical trials, behavioural and psychological studies and post-marketing studies at individual and population levels are needed to answer these and more questions, such as price elasticity for optimal consumer surplus extraction. Claims imputing health benefits, reduced harm or use in smoking cessation should be prohibited until they are scientifically dis-proven. ENDS products should be regulated as nicotine delivery devices in order for stringent barriers to user access as well as barriers to entry and continued operation for small enterprises who are not constituents of pharmaceutical cartels; when such regulation is not possible, they should be subjected under tobacco control laws, to regulation of contents and labelling, prohibitions against public use and restrictions on advertising, promotion and sponsorship. The promotion of a product likely to pose a health benefit to a substantial sub-group of the global population must not continue, and is certainly not endorsed by the World Health Organization[...]

EDIT: Not trying to bash the WHO here, just having some fun with the text. I don't like the alarmist language, however, nor the lack of proper framing - "ENDS" as opposed to tobacco, nor the "save the children" argument as marketing and the reality of the product certainly aren't geared toward them. In conclusion: *sigh*
 
Last edited:

River

Super Member
ECF Veteran
Nov 11, 2009
591
36
Independence, KY USA
Oh noes! heaven forbid ENDS lessening the chance that someone may pass up the chance to get in on that incredibly effective 8% success rate of traditional NRTs!!!

Thanks for saving me from my ignorant laypersoness all you smart people that know how to handle my health decisions better than i do, what would i do without you!!!
 

CJsKee

Super Member
ECF Veteran
Verified Member
Apr 1, 2009
991
26
Oklahoma
1 Preface
This Scientific Recommendation addresses electronic nicotine delivery systems (ENDS) designed for nicotine delivery to the respiratory system. [...]
This recommendation is being made because ENDS pose significant public health issues far less worrisome than tobacco cigarette consumption and raise questions for tobacco taxation and price elasticity of demand given an increased degree of substitutability. Manufacturers have not fully disclosed the chemicals used in ENDS, whereas an approximation of 4,000 chemicals are well documented in cigarettes; there are few data on their emissions or actual human exposure besides 5 years of consumer experience without incidence; their health effects have not been studied in a manner which promotes the financial interests of internationally important fiscal entities i.e. pharmaceutical and tobacco interests; and their marketing and use could undermine public smoking bans (albeit ENDS do not produce products of combustion per se), which are important tobacco control interventions. The products could also undermine smoking cessation efforts by proposing unproven devices for smoking cessation in the place of products of proven efficacy in revenue stream generation. ENDS might also undermine the prevention of tobacco use because of their appearance and marketing as safe alternatives to tobacco products for nontobacco users, including children who would otherwise have opted for traditional, harmful tobacco delivery by commandeering said products from their progenitors. Budget constraints, lack of availability, and non-existence of marketing toward said groups should be assumed non-binding constraints as pertains to this issue [...]

What the hell??? What are they saying here...that "ENDS" pose a threat to the financial interests of BP and BT?

Right...so not a health hazard, but the financial risk to BP and BT are too great? After all, it's all about corporate health, not public health!

Good gawd!
 

justsomeguy

Senior Member
ECF Veteran
Feb 10, 2010
225
0
Texas
What the hell??? What are they saying here...that "ENDS" pose a threat to the financial interests of BP and BT?

Right...so not a health hazard, but the financial risk to BP and BT are too great? After all, it's all about corporate health, not public health!

Good gawd!

I think you read Tarhelldan's edit on the original text....
he was just having some fun with it, but didn't make it exactly clear that it was a joke.

The quotes in the original post are from the original article.

Edited to Add:
Doh! That's what I get for taking too long to write a reply... looks like Tarhelldan beat me to it.
 

CJsKee

Super Member
ECF Veteran
Verified Member
Apr 1, 2009
991
26
Oklahoma
I think you read Tarhelldan's edit on the original text....
he was just having some fun with it, but didn't make it exactly clear that it was a joke.

The quotes in the original post are from the original article.

Edited to Add:
Doh! That's what I get for taking too long to write a reply... looks like Tarhelldan beat me to it.


:lol::lol::lol: Awwww, jeeezzzz....Well, I bet if they thought they could have got away with it, that's what they would have said LOL

Good "editing" Dan ;)
 

Vocalek

CASAA Activist
Supporting Member
ECF Veteran
The products could also undermine smoking cessation efforts by proposing unproven devices for smoking cessation in the place of products of proven efficacy.

The products work so well that they could seriously undermine the profits of the companies that market products with proven failure rates of >90%.
 
Status
Not open for further replies.

Users who are viewing this thread